��������

Lauren Ettin, Chief Executive Officer, and Tim Romualdo, Ambassador, Pediatric Oncology Group of Ontario (POGO), and their team, joined John McKenzie, Chief Executive Officer, TMX Group, to close the market and celebrate raising $ 78, 382 for TMX Ring the Bell in support of POGO. There were 150 participants walking and cycling for this event in Toronto and the greater Toronto area. POGO works to ensure that everyone affected by childhood cancer has access to the best care and support. Their goal is to achieve an excellent childhood cancer care system for children, youth, survivors, and their families and healthcare teams, in Ontario and beyond. POGO champions childhood cancer care, and as the collective voice of this community, is the official advisor to Ontario’s Ministry of Health on children’s cancer control and treatment.

Lauren Ettin, Chief Executive Officer, and Tim Romualdo, Ambassador, Pediatric Oncology Group of Ontario (POGO), and their team joined John McKenzie, Chief Executive Officer, TMX Group, to open the market and celebrate TMX Ring the Bell in support of POGO. This walking and cycling charity event raises funds for POGO and its mission. POGO works to ensure that everyone affected by childhood cancer has access to the best care and support. Their goal is to achieve an excellent childhood cancer care system for children, youth, survivors, and their families and healthcare teams, in Ontario and beyond. POGO champions childhood cancer care, and as the collective voice of this community, is the official advisor to Ontario’s Ministry of Health on children’s cancer control and treatment.

“Company”) and Jeff Sujitno, Portfolio Manager, Wellington Square Advisors, and their teams, joined Keith Wu, Head, Exchange Traded Products, �������� (“TSX”), to close the market and celebrate the launch of the Company’s new ETF: Brompton Wellington Square Investment Grade CLO ETF (TSX: BBBB, BBBB.U). Brompton Wellington Square Investment Grade CLO ETF is designed to provide high monthly income and capital preservation through investment in an actively managed portfolio of primarily investment grade-rated collateralized loan obligations (“CLOs”). CLOs will be selected by the Sub-advisor with a minimum of 75% of the portfolio invested in investment grade CLOs. The ETF may also invest up to 25% of its portfolio in CLOs rated BB+ to B-, provided that no more than 5% of the portfolio is invested in CLOs rated below BB-. Brompton Funds is an experienced investment management firm offering income and growth-oriented investment solutions including exchange-traded funds, split share funds, and other TSX-traded investment funds. Brompton leverages over 25 years of experience to provide unique, well-conceived, and value-added strategies to individual investors in Canada with a focus on meeting investors’ needs by offering innovative products with client-friendly terms and supported by strong corporate governance. Wellington Square Advisors is a Canadian based independent investment manager with long-term track record managing funds investing in CLOs, leveraged loans and corporate credit in the U.S., European and Canadian markets. Wellington Square’s partners have backgrounds within CLO management and managing institutional funds for Canada’s largest pension plans.

Dr. David Lim, Breast Surgical Oncologist, Department of Surgery, Women’s College Hospital, Dr. Christine Brezden-Masley, Medical Oncologist, Mount Sinai Hospital and Kimberly Carson, Chief Executive Officer, Breast Cancer Canada, joined Brenda Cunnington, Managing Director, Americas, Trayport at TMX Group, and Board Director for The Lobular Breast Cancer Alliance (“LBCA”) to open the market in recognition of Lobular Breast Cancer Awareness Day. October is Breast Cancer Awareness month, and the 15th was selected as Lobular Breast Cancer Awareness Day to shine a spotlight on the 15% of breast cancer diagnoses each year that are invasive lobular carcinoma (“ILC”). ILC is the second most common type of breast cancer and it behaves differently from the more common ductal breast cancers, often growing in spidery lines and not lumps making it harder to detect with imaging. As a result, the tumours are often missed on mammograms and ultrasounds. Although scientific studies have confirmed that lobular breast cancer is a distinct breast cancer type, less than 1% of breast cancer research funding has been allocated to study ILC and there are no specific treatments. More research is needed to identify better methods for detection and targeted treatments for patients with ILC. The LBCA is the only organization focused on raising awareness of ILC and is the #1 source for information on lobular breast cancer. In consideration of this effort to raise awareness that a “one size fits all” approach for treating breast cancer is no longer adequate, the City of Toronto has issued an official proclamation declaring October 15th, Lobular Breast Cancer Awareness Day.